Uždaroji akcinė bendrovė "Pharmcos" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 31,438 |
| 15,719 |
| -5,364 |
| -5,364 |
| -2,682 |
| 100.00 |
| -17.06 |
| -274,159 |
| 295,683 |
| 35 |
| 21,489 |
| 2023 |
|---|
| 0 |
| 0 |
| -3,864 |
| -3,864 |
| -1,932 |
| - |
| - |
| -278,023 |
| 299,547 |
| 35 |
| 21,489 |
| 2024 |
|---|
| 0 |
| 0 |
| -4,006 |
| -4,006 |
| -2,003 |
| - |
| - |
| -282,029 |
| 303,388 |
| 35 |
| 21,324 |
Register and
explore Okredo data| 2024 |
|---|
| 0 |
| 0 |
| -4,006 |
| -4,006 |
| -2,003 |
| - |
| - |
| -282,029 |
| 303,388 |
| 35 |
| 21,324 |
Register and
explore Okredo dataTurnover (€)
2024
Turnover (€)
0 €- *
Sales per employee (€)
0 €- *
Profit before tax (€)
-4,006 €-4 % *
Net Profit (€)
-4,006 €-4 % *
Profit per employee (€)
-2,003 €-4 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
-282,029 €-1 % *
Amounts Payable And Liabilities (€)
303,388 €1 % *
Non-current Assets (€)
35 €0 % *
CurrentAssets (€)
21,324 €-1 % *
